期刊文献+
共找到139篇文章
< 1 2 7 >
每页显示 20 50 100
Multivariate Analysis of Clinical Factors in Restenosis after Coronary Stenting
1
作者 温尚煜 毛节明 +4 位作者 郭丽君 赵一鸣 张福春 郭静萱 陈明哲 《South China Journal of Cardiology》 CAS 2000年第1期6-8,共3页
Ojbective To find the independent predictors for restenosis after coronary stenting. Methods Quantitative angiography was performed on 60 cases (67 successfully dilated lesions) after angio-plasty over 6-months follow... Ojbective To find the independent predictors for restenosis after coronary stenting. Methods Quantitative angiography was performed on 60 cases (67 successfully dilated lesions) after angio-plasty over 6-months follow-up, and both univariate and multivariate logistic regression analysis were done to i-dentify the correlations of restenosis with clinical factors. Results The total restenosis rate was 31. 3% (21 of 67 lesions), and according to univariate analysis the patients who underwent coronary stenting≥ 3. 5mm had a lower rate of restenosis ( P < 0. 01). Collateral circulation to the obstruction site, high maximal inflation pressure, smoking and the less minimal lumen diameter after PTCA made the rate of restenosis higherower ( P < 0. 05) . Multivariate logistic regression analysis showed that coronary stenting ≥3. 5mm had a low rate of restenosis, but high maximal inflation pressure and smoking made the restenosis rate higher. Conclusion Coronary stent size, maximal inflation pressure and. smoking were independent predictors for restenosis. 展开更多
关键词 coronary artery angioplasty clinical factor restenosis Stenting
下载PDF
Clinico-Angiographic Profile and Prevalence of Restenosis in Patients Undergoing Percutaneous Transluminal Coronary Angioplasty to Left Main Coronary Artery: An Observational Cohort Study
2
作者 Dolly Mathew C. G. Sajeev 《World Journal of Cardiovascular Diseases》 2017年第11期413-422,共10页
Background: Patients who underwent percutaneous coronary intervention in left main coronary artery (LMCA) requires special concern, being high risk and increasing patient population. The aim of this study was to asses... Background: Patients who underwent percutaneous coronary intervention in left main coronary artery (LMCA) requires special concern, being high risk and increasing patient population. The aim of this study was to assess the clinical profile, angiographic status, and prevalence of restenosis in patients who underwent percutaneous transluminal coronary angioplasty (PTCA) in LMCA. Materials and Methods: This observational cohort study included 17 patients who underwent PTCA in LMCA during one-year study period at tertiary care centers in Government Medical College, Kozhikode, India. Data including various risk factors, clinical and angiographic details, stent used, procedural complications and outcomes including rate of restenosis were analyzed. Results: A total of 17 patients (mean age 53.88 ± 9.80 years) with 76.47% of males were included in the study. Smoking and hypertension were the most common risk factors presented in 52.94% and 47.06% of patients respectively. Single vessel disease (SVD) of LMCA was the most common pattern observed in 47.10%;the rate of restenosis was observed in 11.76% patients. Revascularization was performed in one patient (5.88%) with coronary artery bypass graft and in one patient (5.88%) with PTCA using drug eluting stent (DES). The overall procedural success was 88.24% in this study. Survival rate was 100% at one-year follow-up period. Conclusion: Our study involved patients who underwent PTCA in LMCA, showed smoking as a most prevalent risk factor for coronary artery disease and SVD as a most common pattern, comparatively low rate of restenosis and 100% of survival rate at one-year follow-up period. 展开更多
关键词 coronary artery Disease Drug Eluting Stent In-Stent restenosis Left Main coronary artery Percutaneous TRANSLUMINAL coronary angioplasty
下载PDF
Clinical Observation on Antiruisi Prescription (安替瑞丝方) in Preventing Restenosis after Coronary Artery Stenting
3
作者 贾海忠 史载祥 +3 位作者 柯元楠 叶小筠 周玉杰 马长生 《Chinese Journal of Integrated Traditional and Western Medicine》 2004年第2期141-143,共3页
Antiruisi (AR)prescription (安替瑞丝方) is a compound in Chinese drug-therapy, which was used to treat 35 patients with coronary heart disease after stenting by the authors, and a satisfactory effect had been proved i... Antiruisi (AR)prescription (安替瑞丝方) is a compound in Chinese drug-therapy, which was used to treat 35 patients with coronary heart disease after stenting by the authors, and a satisfactory effect had been proved in preventing restenosis. It is reported as follows. 展开更多
关键词 in Preventing restenosis after coronary artery Stenting clinical Observation on Antiruisi Prescription ECG CAS
下载PDF
A Nomogram to Predict Patients with Obstructive Coronary Artery Disease: Development and Validation 被引量:1
4
作者 Zesen Han Lihong Lai +1 位作者 Zhaokun Pu Lan Yang 《Cardiovascular Innovations and Applications》 2021年第2期245-255,共11页
Objective:To develop and validate clinical prediction models for the development of a nomogram to estimate the probability of patients having coronary artery disease(CAD).Methods and Results:A total of 1,025 patients ... Objective:To develop and validate clinical prediction models for the development of a nomogram to estimate the probability of patients having coronary artery disease(CAD).Methods and Results:A total of 1,025 patients referred for coronary angiography were included in a retrospective,single-center study.Randomly,720 patients(70%)were selected as the development group and the other patients were selected as the validation group.Multivariate logistic regression analysis showed that the seven risk factors age,sex,systolic blood pressure,lipoprotein-associated phospholipase A 2,type of angina,hypertension,and diabetes were signifi cant for diagnosis of CAD,from which we established model A.We established model B with the risk factors age,sex,height,systolic blood pressure,low-density lipoprotein cholesterol,lipoprotein-associated phospholipase A 2,type of angina,hypertension,and diabetes via the Akaike information criterion.The risk factors from the original Framingham Risk Score were used for model C.From comparison of the areas under the receiver operating characteristic curve,net reclassifi cation improvement,and integrated discrimination improvement of models A,B,and C,we chose model B to develop the nomogram because of its fi tness in discrimination,calibration,and clinical effi ciency.The nomogram for diagnosis of CAD could be used easily and conveniently.Conclusion:An individualized clinical prediction model for patients with CAD allowed an accurate estimation in Chinese populations.The Akaike information criterion is a better method in screening risk factors.The net reclassifi-cation improvement and integrated discrimination improvement are better than the area under the receiver operating characteristic curve in discrimination.Decision curve analysis can be used to evaluate the effi ciency of clinical prediction models. 展开更多
关键词 coronary artery disease risk factors clinical decision rules NOMOGRAM
下载PDF
Drug eluting balloons for the treatment of coronary artery disease: What can we expect?
5
作者 Alexander Joost Volkhard Kurowski Peter W Radke 《World Journal of Cardiology》 CAS 2010年第9期257-261,共5页
Drug-eluting balloons (DEBs) represent an enhancement of the therapeutic repertoire for the interventional cardiologist. The therapeutic concept of DEBs is promising, notably on the basis of initial studies in patient... Drug-eluting balloons (DEBs) represent an enhancement of the therapeutic repertoire for the interventional cardiologist. The therapeutic concept of DEBs is promising, notably on the basis of initial studies in patients with diffuse in-stent restenosis (ISR). At present, however, a number of questions regarding long-term efficacy and safety remain, specifically in indications other than diffuse ISR. The results of the evaluation of different substances, balloon systems and clinical indications will determine the long-term success of DEBs. 展开更多
关键词 coronary artery disease coronary balloon angioplasty DRUG delivery systems Vascular graft restenosis
下载PDF
Comparison of pre-dilation with a non-compliant balloon versus a dual wire scoring balloon for coronary stenting
6
作者 Kenji Sadamatsu Keiki Yoshida +3 位作者 Yuya Yoshidomi Yasuaki Koga Kaori Amari Tomotake Tokunou 《World Journal of Cardiovascular Diseases》 2013年第6期395-400,共6页
Purpose: The aim of this study was to determine the influence of lesion preparation using the dual wire scoring balloon on stent expansion and long-term outcomes. Methods: Forty-six consecutive de novo lesions treated... Purpose: The aim of this study was to determine the influence of lesion preparation using the dual wire scoring balloon on stent expansion and long-term outcomes. Methods: Forty-six consecutive de novo lesions treated with a single >2.5 mm drug-eluting stent under intravascular ultrasound guidance, using two implantation strategies, were randomly assigned to: 1) pre-dilation with a non-compliant balloon (NC group;n = 23) or 2) pre-dilation with a dual wire scoring balloon (DS group;n = 23). Results: Although the balloon size and the maximal dilation pressure for pre-dilatation was larger (3.33 ± 0.28 vs 3.09 ± 0.33 mm, p = 0.01) and higher (11.6 ± 3.2 vs 8.6 ± 2.7 atm, 展开更多
关键词 INTRAVASCULAR Ultrasound Stent coronary artery Disease restenosis angioplasty
下载PDF
Cutting balloon angioplasty for treatment of coronary in-stent restenosis: immediate results and 6-month outcomes 被引量:2
7
作者 陈绍良 段宝祥 +8 位作者 刘志忠 吴翔 魏福祥 钱学礼 叶飞 方五旺 胡作英 Isreal Tamari 陈淮沁 《Chinese Medical Journal》 SCIE CAS CSCD 2002年第2期166-169,144-145,共4页
OBJECTIVE: To determine the mid-term effects of cutting balloon angioplasty (CBA) on in-stent restenosis. METHODS: A total of 69 patients with in-stent restenosis were divided into 2 groups randomly: cutting balloon a... OBJECTIVE: To determine the mid-term effects of cutting balloon angioplasty (CBA) on in-stent restenosis. METHODS: A total of 69 patients with in-stent restenosis were divided into 2 groups randomly: cutting balloon angioplasty and plain old balloon angioplasty. The mechanisms of restenosis and dilation results were determined by quantitative coronary angiography and intravascular ultrasound. Follow-up was performed. RESULTS: The procedural success rate was 100% without death and acute closure. One patient experienced dissection at the distal end of the stent and needed another stent. The mean follow-up period was 6.7 +/- 2.3 months. The final re-restenosis rate was 15% and 18% at 3 months and 6 months respectively, markedly lower than after plain old balloon angioplasty (38% and 43%). Acute gain by intravascular ultrasound (IVUS) was 1.72 +/- 0.52 mm after cutting balloon angioplasty, higher than 1.15 +/- 0.54 mm after plain old balloon angioplasty. The lumen diameter late loss in the cutting balloon group was 0.26 +/- 0.05 mm and 0.38 +/- 0.06 mm at 3 months and 6 months respectively, significantly lower than for those in conventional balloon group (0.78 +/- 0.19 mm and 0.89 +/- 0.16 mm, respectively, P 展开更多
关键词 STENTS Aged angioplasty Balloon Comparative Study coronary Angiography coronary restenosis coronary Vessels Female Follow-Up Studies Humans Male Middle Aged Time factors Treatment Outcome
原文传递
国医大师翁维良治疗冠心病支架术后再狭窄的长时医案
8
作者 付荩毅 张菀桐 +2 位作者 王旭杰 李睿 翁维良 《天津中医药》 CAS 2024年第8期957-962,共6页
冠状动脉支架置入术后再狭窄(ISR)是目前临床的一大难题。文章通过长时医案可视化分析,探讨国医大师翁维良治疗ISR的学术思想,为ISR提供中医药诊疗思路。翁教授强调治未病,认为ISR的核心病机为气虚血瘀,治疗以益气活血为核心。擅长运用... 冠状动脉支架置入术后再狭窄(ISR)是目前临床的一大难题。文章通过长时医案可视化分析,探讨国医大师翁维良治疗ISR的学术思想,为ISR提供中医药诊疗思路。翁教授强调治未病,认为ISR的核心病机为气虚血瘀,治疗以益气活血为核心。擅长运用多种活血药,包括理气活血的延胡索、郁金,凉血活血的赤芍、丹参,补血活血的鸡血藤和破血行气的三棱、莪术等。灵活运用多种参类药益气扶正,如红参、人参、太子参、党参等;同时注意调和阴阳,常用高良姜温阳和沙参养阴。 展开更多
关键词 冠心病 再狭窄 长时医案 临证经验 翁维良
下载PDF
Early outcomes and analysis of factors influencing in-hospital mortality after concomitant heart valve replacement and coronary artery bypass grafting 被引量:1
9
作者 ZHENG Hai-yun WU Hao +1 位作者 HE Xiao-ling ZHU Ping 《South China Journal of Cardiology》 CAS 2022年第1期95-102,F0003,共9页
Background Objective:To investigate the perioperative precautions,surgical methods and early clinical efficacy of patients with valvular heart disease complicated by coronary atherosclerotic heart disease treated with... Background Objective:To investigate the perioperative precautions,surgical methods and early clinical efficacy of patients with valvular heart disease complicated by coronary atherosclerotic heart disease treated with coronary artery bypass grafting at the same time as heart valve replacement and to analyze the relevant factors affecting the death of patients during hospitalization after surgery.Methods:Between January 2020 and September 2021,a total of 103 patients who underwent simultaneous heart valve replacement and coronary artery bypass grafting for heart valve disease in conjunction with coronary atherosclerotic heart disease at the Department of cardiac surgery,Guangdong Cardiovascular Institute were retrospectively evaluated for clinical data,and a systematic review and summary of all preoperative data,surgical methods,intraoperative data,and major complications were performed.The variations in each cardiotocography indicator were examined before and after surgery to determine surgical effectiveness and statistical perioperative patient mortality.After integrating the Sino SCORE risk assessment system and analyzing the case features included in this data,12 alternative risk variables for mortality were identified and submitted to univariate and multivariate analysis using logistic regression.After performing a univariate analysis of the alternative risk factors,the option of P<0.05 was considered a risk factor and included in the multivariate analysis,followed by a multivariate logistic regression analysis in which the factors were determined to be independent risk factors with P<0.05,and their OR values and 95 percent confidence intervals(CIs)were calculated to analyze the associated factors affecting patients’early prognosis systematically.Results:Of the 103 patients,91 were successfully discharged from the hospital,12 died,11.7%of the deaths were due to the following causes:postoperative low cardiac output syndrome,multiple organ failure,and severe infection;Among all the 103 patients,7 patients underwent rebleeding and hemostasis after surgery,6 patients required dialysis after surgery,28 patients underwent IABP supportive care after surgery because of the occurrence of low cardiac output syndrome,1 patient assisted by ECMO after surgery,and patients discharged successfully had significantly less LVEDD and LVESD in the early postoperative period,compared with those before surgery(P=0.000;P=0.000).Age>70 years,preoperative combined hyperlipidemia,and history of the cerebrovascular accident were the three independent risk factors that may have contributed to in-hospital mortality in patients undergoing CABG valve replacement.Conclusions:1.The diastolic function of the majority of patients with valvular heart disease and coronary atherosclerotic heart disease improved significantly in the early stages after coronary artery bypass grafting and heart valve replacement.2.Age>70 years,preoperative combined hyperlipidemia,and a history of the cerebrovascular accident were three independent risk factors for in-hospital death in patients receiving CABG valve replacement. 展开更多
关键词 Valvular heart disease coronary atherosclerotic heart disease Heart valve replacement coronary artery bypass grafting clinical efficacy Influence factor
原文传递
冠状动脉支架置入后再狭窄危险因素的Logistic回归分析 被引量:16
10
作者 梁祥文 李平 +3 位作者 甘剑挺 王正东 陈坚 谢文超 《中国动脉硬化杂志》 CAS CSCD 北大核心 2014年第3期283-286,共4页
目的探讨冠状动脉支架置入术后再狭窄的相关危险因素。方法对我院行冠状动脉支架置入并行冠状动脉造影随访患者171例的临床资料进行回顾性分析。根据造影随访结果其中术后48例患者中的56支靶血管发生再狭窄作为病例组,未发生再狭窄患者... 目的探讨冠状动脉支架置入术后再狭窄的相关危险因素。方法对我院行冠状动脉支架置入并行冠状动脉造影随访患者171例的临床资料进行回顾性分析。根据造影随访结果其中术后48例患者中的56支靶血管发生再狭窄作为病例组,未发生再狭窄患者123例,133支血管作为对照组。先采用Pearson卡方单因素分析,将单因素分析存在统计学差异的临床变量纳入Logistic回归方程,计算冠状动脉支架置入术后再狭窄的独立危险因素。结果单因素分析显示:术前狭窄程度〉90%(X^2=4.71,P=0.03)、支架直径≤3mm(X^2=27.92,P=0.00)、病变长度〉15mm(X^2=4.67,P=0.03)、残余狭窄〉5%(X^2=10.05,P=0.00)、吸烟患者(X^2=4.78,P=0.03)、糖尿病患者(X^2=4.72,P=0.03)和术后不规范抗凝(X。=6.70,P=0.01)与术后支架内再狭窄有关;Logistic回归分析显示支架直径≤3mm(OR=4.34,95%CI:2.01-8.38,P=0.02)、残余狭窄〉5%(OR=2.2,95%CI:1.56~4.88,P=0.03)和术后不规范抗凝(OR=1.88,95%CI:1.21~3.68,P=0.04)是影响冠状动脉术后再狭窄的独立危险因素。风险比例模型显示,置入支架直径≤3mm患者随访期间发生再狭窄的风险显著高于支架直径〉3mm患者(HR=3.53,95%CI:2.08~5.99,P=0.00)。结论置入支架直径较小、残余狭窄较重且术后抗凝不规范的患者是支架植入术后再狭窄的危险人群,应加强监测,规范抗凝,降低其再狭窄的发生风险。 展开更多
关键词 冠状动脉疾病 再狭窄 危险因素 LOGISTIC回归
下载PDF
30例PCI后支架内再狭窄临床分析 被引量:7
11
作者 周志文 石蓓 +3 位作者 谭敏 周安婵 许官学 刘西平 《中国心血管病研究》 CAS 2007年第2期116-117,共2页
目的分析经皮冠状动脉介入治疗术(PCI)后支架内再狭窄(ISR)的临床情况,探索其规律。方法统计我院近3年确诊的30例ISR患者第一次PCI前病因、冠状动脉血管病变情况及支架种类。结果金属支架、多支病变和急性心肌梗死(AMI)支架内再狭窄所... 目的分析经皮冠状动脉介入治疗术(PCI)后支架内再狭窄(ISR)的临床情况,探索其规律。方法统计我院近3年确诊的30例ISR患者第一次PCI前病因、冠状动脉血管病变情况及支架种类。结果金属支架、多支病变和急性心肌梗死(AMI)支架内再狭窄所占比例最高,30例ISR患者中,共有13例为AMI时行冠脉内支架置入术。结论除金属支架、多支病变等因素外,AMI可能由于其本身的病变特征,易致PCI后ISR。 展开更多
关键词 血管形成术 经腔 经皮冠状动脉 冠状动脉再狭窄 危险因素
下载PDF
早发冠心病急性心肌梗死的危险因素及临床特点分析 被引量:68
12
作者 刘浩 武刚 +5 位作者 翟雪芹 吴致安 韩轶 李超 王晓峰 周贤慧 《中国全科医学》 CAS CSCD 北大核心 2012年第11期1205-1208,共4页
目的探讨早发冠心病急性心肌梗死(AMI)的危险因素、临床特点和冠状动脉造影(CAG)特点。方法收集经CAG确诊的AMI患者504例,按发病年龄分为早发组(男≤55岁,女≤65岁)288例和晚发组(男>55岁,女>65岁)216例,对比分析早发组的心血管... 目的探讨早发冠心病急性心肌梗死(AMI)的危险因素、临床特点和冠状动脉造影(CAG)特点。方法收集经CAG确诊的AMI患者504例,按发病年龄分为早发组(男≤55岁,女≤65岁)288例和晚发组(男>55岁,女>65岁)216例,对比分析早发组的心血管病危险因素、临床特点和冠状动脉病变特点。结果 (1)早发组患者以男性为主;多超重;吸烟史、饮酒史、高脂血症、阳性家族史明显多于晚发组(均P<0.05);晚发组患者中原发性高血压检出率高于早发组(P<0.05),糖尿病检出率也明显高于早发组(P<0.01)。(2)早发组TG水平明显高于晚发组,舒张压、高密度脂蛋白胆固醇水平明显低于晚发组(均P<0.05)。(3)早发组患者以单支病变为主,前降支最易受累,左主干较少受累,但死亡率高。(4)多因素Logistic回归分析显示吸烟史、阳性家族史、高TG、高血压、糖尿病等是早发冠心病AMI的独立危险因素。结论吸烟、饮酒、阳性家族史、以TG升高为主的脂质代谢紊乱等是早发冠心病AMI的主要危险因素;早发组患者的主要临床特点为男性所占比例高,高血压、糖尿病发生率低,CAG病变部位早发冠心病AMI患者病变多以单支病变为主,三支血管及左主干病变、严重、弥漫性病变少见,但累及左主干病变死亡率高。 展开更多
关键词 早发冠心病 急性心肌梗死 危险因素 临床特点
下载PDF
经皮冠状动脉介入治疗术后支架内再狭窄的多因素Logistic回归分析 被引量:22
13
作者 刘征 于卫国 +4 位作者 张蕾 陈金良 李海军 张福利 高翊森 《中国循证心血管医学杂志》 2016年第3期317-319,共3页
目的 分析经皮冠状动脉介入治疗(PCI)术后出现支架内再狭窄的危险因素,为预防支架内再狭窄提供理论依据。方法 回顾性分析2010年3月~2015年1月于北京军区北戴河疗养院就诊的PCI术后疑似冠状动脉再狭窄的患者126例的资料,其中男性87例... 目的 分析经皮冠状动脉介入治疗(PCI)术后出现支架内再狭窄的危险因素,为预防支架内再狭窄提供理论依据。方法 回顾性分析2010年3月~2015年1月于北京军区北戴河疗养院就诊的PCI术后疑似冠状动脉再狭窄的患者126例的资料,其中男性87例,女性39例,平均年龄(57.2±9.8)岁。依据冠状动脉造影结果分为再狭窄组(n=36)和对照组(n=90)。所有患者均行冠状动脉造影术,计算冠状动脉Gensini积分,检测两组低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、总胆固醇(TC)、三酰甘油(TG)、空腹血糖(FPG)和葡萄糖耐量试验(OGTT)等指标。结果 与对照组比较,再狭窄组男性、吸烟、高血压、糖尿病比例,冠状动脉Gensini积分,TG、TC、LDL-C水平,支架长度和支架数量均增加,HDL-C水平和支架直径降低,差异有统计学意义(P均〈0.05)。糖尿病(OR=7.130,95%CI:1.680~12.754)、术后吸烟(OR=2.419,95%CI:1.013~6.215)、冠状动脉Gensini积分(OR=10.537,95%CI:3.678~18.845)、支架长度(OR=1.593,95%CI:1.072~2.393)和支架数量(OR=2.541,95%CI:1.169~3.745)是PCI术后支架内再狭窄的独立危险因素。支架直径(OR=0.659,95%CI:0.485~0.873)是PCI术后支架内再狭窄的保护因素。结论 糖尿病、吸烟、冠状动脉Gensini积分、支架长度和数量是PCI术后支架内再狭窄的独立危险因素,而较大的支架直径则是保护因素。 展开更多
关键词 冠状动脉 支架内再狭窄 冠状动脉造影术 危险因素
下载PDF
基质交感分子1和骨保护素对急性冠脉综合征合并2型糖尿病患者经皮冠状动脉介入治疗术后支架内再狭窄的影响研究 被引量:10
14
作者 李海滨 姜志安 +1 位作者 张晓光 王涛 《中国全科医学》 CAS CSCD 北大核心 2015年第22期2680-2683,共4页
目的探讨基质交感分子1(STIM1)和骨保护素(OPG)对急性冠脉综合征(ACS)合并2型糖尿病(T2DM)患者经皮冠状动脉介入治疗(PCI)术后支架内再狭窄(ISR)的影响。方法选取2012年10月—2013年10月河北医科大学第三医院心内科收治的100例ACS合并T... 目的探讨基质交感分子1(STIM1)和骨保护素(OPG)对急性冠脉综合征(ACS)合并2型糖尿病(T2DM)患者经皮冠状动脉介入治疗(PCI)术后支架内再狭窄(ISR)的影响。方法选取2012年10月—2013年10月河北医科大学第三医院心内科收治的100例ACS合并T2DM患者为研究对象,均成功行PCI术。于术后8个月复查冠状动脉造影,根据是否存在ISR,分为ISR组35例和对照组65例。记录100例患者的性别、年龄、高血压、吸烟等一般资料;在PCI术前,测定患者的高敏C反应蛋白(hs-CRP)、血脂、血糖等生化指标;在PCI术后,测定患者的STIM1和OPG水平。结果两组的年龄、性别、吸烟率、高血压患病率比较,差异均无统计学意义(P>0.05)。两组患者的总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、空腹血糖(FPG)水平比较,差异均无统计学意义(P>0.05);hs-CRP、STIM1、OPG水平比较,差异均有统计学意义(P<0.05)。多因素Logistic回归分析显示,hs-CRP、STIM1、OPG对PCI术后发生ISR的影响有统计学意义(P<0.05)。结论 STIM1、OPG是ACS合并T2DM患者PCI术后发生ISR的危险因素。 展开更多
关键词 支架内再狭窄 血管成形术 气囊 冠状动脉 基质交感分子1 骨保护素 影响因素分析
下载PDF
急性ST段抬高型心肌梗死患者急诊经皮冠状动脉介入治疗前后血清血管内皮生长因子及高敏C反应蛋白水平变化与术后再狭窄 被引量:13
15
作者 王福华 郭靖涛 +1 位作者 周江 代燕燕 《临床荟萃》 CAS 2014年第11期1217-1221,共5页
目的联合检测急诊经皮冠状动脉介入治疗(PCI)前后血清血管内皮生长因子(VEGF)及高敏C反应蛋白(hs-CRP)水平变化,旨在探讨急诊PCI术前后血清VEGF及hs-CRP水平变化与急诊PCI术后再狭窄的关系。方法检测100例急诊PCI的ST段抬高型心肌梗死(S... 目的联合检测急诊经皮冠状动脉介入治疗(PCI)前后血清血管内皮生长因子(VEGF)及高敏C反应蛋白(hs-CRP)水平变化,旨在探讨急诊PCI术前后血清VEGF及hs-CRP水平变化与急诊PCI术后再狭窄的关系。方法检测100例急诊PCI的ST段抬高型心肌梗死(STEMI)患者术前、术后3天、术后7天血清中VEGF、hs-CRP水平,根据6个月随访冠状动脉造影结果分为再狭窄组和无再狭窄组,分析急诊PCI术后3天和术后7天血清VEGF及hs-CRP变化水平与术后再狭窄的关系。结果急诊PCI术前血清VEGF水平高于术后3天和7天水平(P<0.01);急诊PCI术前血清hs-CRP水平低于术后3天水平,而高于术后7天水平(P<0.01)。再狭窄组急诊PCI术前血清VEGF水平显著低于无再狭窄组(P<0.05);术后3天血清VEGF水平与无再狭窄组无明显差别(P>0.05);术后7天血清VEGF水平与无再狭窄组无明显差别(P>0.05);术后3天血清VEGF下降幅度明显低于无再狭窄组(P<0.05)。再狭窄组急诊PCI术前血清hs-CPR水平与无再狭窄组无差别(P>0.05);术后3天血清hsCRP水平与无再狭窄组无明显差别(P>0.05);术后7天血清hs-CPR水平与无再狭窄组无明显差别(P>0.05);术后3天血清hs-CPR升高幅度明显高于无再狭窄组(P<0.05)。急诊PCI术后3天血清VEGF下降幅度与急诊PCI术后支架再狭窄呈负相关(rs=-0.411,P<0.05);术后3天血清hs-CPR升高幅度与急诊PCI术后支架再狭窄呈正相关(rs=0.414,P<0.05)。结论急诊PCI术后3天血清VEGF及hs-CRP变化水平与急诊PCI术后再狭窄高度相关,联合检测急诊PCI术后3天血清VEGF下降的幅度及术后3天血清hs-CRP升高的幅度,或可成为预测急诊PCI术后再狭窄的生化指标。 展开更多
关键词 冠心病 心肌梗死 血管内皮生长因子类 C反应蛋白质 血管成形术 冠状动脉 冠状动脉再狭窄
下载PDF
经皮冠状动脉腔内成形术后再狭窄与介入前病变形态学的关系 被引量:7
16
作者 蔡煦 沈卫峰 +3 位作者 于金德 张大东 张建盛 龚兰生 《中国循环杂志》 CSCD 北大核心 1999年第5期266-268,共3页
目的:探讨国人冠心病经皮冠状动脉腔内成形术(PTCA)后再狭窄与冠状动脉(冠脉)病变类型、部位和病变血管数的关系。  方法:冠心病介入治疗352 例,选择其中65 例(86个病变)术后3~16个月造影随访者,按随访结果... 目的:探讨国人冠心病经皮冠状动脉腔内成形术(PTCA)后再狭窄与冠状动脉(冠脉)病变类型、部位和病变血管数的关系。  方法:冠心病介入治疗352 例,选择其中65 例(86个病变)术后3~16个月造影随访者,按随访结果分为再狭窄组(n= 38),非再狭窄组(n= 27),分析再狭窄与病变形态学的关系。  结果:再狭窄与多个易患因子、多支病变、病变类型和前降支病变呈正相关,与支架置入呈负相关。再狭窄组C型、钙化病变多见,前降支病变内径丢失比回旋支、右冠脉病变大(P< 0.05),半年内一支血管病变再狭窄率(10.27% )低于二支(41.10% )和三支(48.50% )血管病变再狭窄率(P< 0.0001)。  结论:再狭窄与冠脉病变类型、部位和血管支数相关,C型及钙化。 展开更多
关键词 冠心病 PTCA 血管成形术
下载PDF
联合应用准分子激光冠状动脉斑块消融术和药物涂层球囊治疗冠状动脉支架内再狭窄的观察性研究 被引量:10
17
作者 杨丽霞 周玉杰 +4 位作者 王志坚 史冬梅 柴萌 梁静 张琳琳 《中国医药》 2020年第8期1174-1177,共4页
目的对比联合应用准分子激光冠状动脉斑块消融术(ELCA)和药物涂层球囊(DCB)与单独应用DCB治疗冠状动脉支架内再狭窄(ISR)的效果。方法选取2017年1月至2019年12月在首都医科大学附属北京安贞医院应用DCB处理冠状动脉ISR并接受光学相干断... 目的对比联合应用准分子激光冠状动脉斑块消融术(ELCA)和药物涂层球囊(DCB)与单独应用DCB治疗冠状动脉支架内再狭窄(ISR)的效果。方法选取2017年1月至2019年12月在首都医科大学附属北京安贞医院应用DCB处理冠状动脉ISR并接受光学相干断层成像检查的患者32例。根据是否接受ELCA将患者分为ELCA组(应用ELCA联合DCB,12例,15处病变)和对照组(单独应用DCB,20例,24处病变)。比较2组光学相干断层成像测量治疗前后的即刻管腔获得、支架扩张面积及术中不良事件发生情况。结果ELCA组即刻管腔获得明显高于对照组[(3.4±0.9)mm^2比(1.9±0.5)mm^2](P=0.03),2组支架扩张面积比较,差异无统计学意义(P=0.91)。ELCA组和对照组各有1例患者DCB应用后出现A型或B型夹层,未予进一步处理。对照组1例患者第1个DCB通过困难,经再次处理后第2个DCB通过。ELCA组1例、对照组2例出现无复流,对症治疗后好转。结论联合应用ELCA和DCB治疗ISR较单独应用DCB治疗ISR能得到更大的即刻管腔获得,且不增加并发症发生率。 展开更多
关键词 冠状动脉支架再狭窄 准分子激光 药物球囊
下载PDF
持续炎症状态对冠状动脉支架内再狭窄的影响和预测分析 被引量:3
18
作者 许海燕 张家芬 +3 位作者 乔树宾 李建军 杨跃进 徐波 《中华老年心脑血管病杂志》 CAS 北大核心 2010年第10期870-872,共3页
目的探讨PCI前后持续炎症状态对PCI后支架内再狭窄的影响和预测作用。方法选择成功行支架置入术并于3个月后至1年内复查冠状动脉造影的患者431例,分为支架内再狭窄组(再狭窄组)124例和无支架内再狭窄组(无再狭窄组)307例。患者于PC... 目的探讨PCI前后持续炎症状态对PCI后支架内再狭窄的影响和预测作用。方法选择成功行支架置入术并于3个月后至1年内复查冠状动脉造影的患者431例,分为支架内再狭窄组(再狭窄组)124例和无支架内再狭窄组(无再狭窄组)307例。患者于PCI前及复查冠状动脉造影时均检测C反应蛋白(CRP)、高敏CRP(hs-CRP)。结果与无再狭窄组比较,再狭窄组患者PCI前CRP和hs-CRP以及PCI后CRP均明显升高,差异有统计学意义(P〈0.05,P〈0.01)。将PCI前hs-CRP分为〉2mg/L和≤2mg/L2个等级,hs-CRP增高的患者支架内再狭窄的发生率明显升高(χ^2=5.03,P〈0.05)。logistic回归分析显示,hs-CRP高的患者发生支架内再狭窄的风险明显增加(OR=1.840,95%CI:1.076~3.157,P〈0.05)。结论PCI前后持续的炎症状态是发生支架内再狭窄的危险因素和预测指标,应积极加强抗炎以改善PCI后患者的临床预后。 展开更多
关键词 支架 血管成形术 经腔 经皮冠状动脉 炎症 冠状动脉疾病 冠状动脉再狭窄 预测 冠状血管造影术
下载PDF
冠脉支架植入术后支架内再狭窄的危险因素分析 被引量:12
19
作者 王舒 杨庭树 +1 位作者 齐冠名 王磊 《心血管康复医学杂志》 CAS 2007年第6期563-565,共3页
目的:探讨冠状动脉支架植人术后支架内再狭窄发生的危险因素。方法:对2006年1月1日至2006年12月31日在我院行冠状动脉支架植入术后行冠状动脉造影随访的121例资料进行了回顾性分析。统计学上采用logis-tic多因素逐步回归分析。结果:多因... 目的:探讨冠状动脉支架植人术后支架内再狭窄发生的危险因素。方法:对2006年1月1日至2006年12月31日在我院行冠状动脉支架植入术后行冠状动脉造影随访的121例资料进行了回顾性分析。统计学上采用logis-tic多因素逐步回归分析。结果:多因素logistic回归分析显示再狭窄与患者是否有糖尿病,是否吸烟以及第二次冠脉介入治疗前LDL-C水平成显著正相关,其相对危险度(RR)分别为11.55、5.48和12.60;而与支架是否为药物涂层成负相关,RR为0.01。结论:糖尿病患者为支架术后再狭窄的的高危人群,药物支架可减少再狭窄的发生。对于支架植入术后的患者,戒烟以及控制LDL-C的水平是减少支架内再狭窄的关键因素。 展开更多
关键词 冠状动脉疾病 支架 冠状动脉再狭窄 危险因素
下载PDF
冠脉内支架植入术后再狭窄的影响因素分析 被引量:8
20
作者 刘灵芝 侯翠红 刘恒亮 《郑州大学学报(医学版)》 CAS 北大核心 2005年第3期533-535,共3页
目的:探讨冠脉内支架植入术后再狭窄的影响因素。方法:选择随访的冠脉造影资料较全的100例冠脉内支架植入术后患者。依据术后冠脉造影复查结果将其分为无再狭窄组和再狭窄组,比较2组临床危险因素(包括年龄、性别、高血压、糖尿病、高脂... 目的:探讨冠脉内支架植入术后再狭窄的影响因素。方法:选择随访的冠脉造影资料较全的100例冠脉内支架植入术后患者。依据术后冠脉造影复查结果将其分为无再狭窄组和再狭窄组,比较2组临床危险因素(包括年龄、性别、高血压、糖尿病、高脂血症、吸烟)及靶血管病变特点(如病变部位、病变分型、病变长度、术前狭窄程度、最小管腔直径、病变血管支数),分析支架内再狭窄的影响因素。结果:2组年龄、高血压患病率、糖尿病患病率、高脂血症患病率、病变部位、病变分型、病变血管支数差异无统计学意义。再狭窄组男女比例(396)较无再狭窄组(2926)高(P=0.02);再狭窄组吸烟比例(80%)较无再狭窄组(58.6%)高(P=0.03);再狭窄组术前狭窄程度(94.65%±3.62%)较无再狭窄组(88.81%±3.23%)重(P=0.04);再狭窄组病变长度(23.2±10.8)mm较无再狭窄组的(17.6±11.8)mm长(P=0.04)。结论:年龄、高血压患病率、糖尿病患病率、高脂血症患病率、病变部位、病变分型、病变血管支数对冠脉内支架植入术后再狭窄无关,男性、吸烟、病变长度、术前狭窄程度与其有关。 展开更多
关键词 支架 再狭窄 冠状动脉疾病 影响因素
下载PDF
上一页 1 2 7 下一页 到第
使用帮助 返回顶部